Scheer David 4
4 · ACHILLION PHARMACEUTICALS INC · Filed Nov 14, 2019
Insider Transaction Report
Form 4
Scheer David
Director
Transactions
- Exercise/Conversion
Common Stock
2019-11-13$3.28/sh+20,000$65,600→ 40,000 total - Exercise/Conversion
Stock Option (Right to Buy)
2019-11-13−20,000→ 0 totalExercise: $3.28Exp: 2019-12-18→ Common Stock (20,000 underlying) - Sale
Common Stock
2019-11-13$6.31/sh−10,485$66,197→ 29,515 total
Holdings
- 63,249(indirect: See footnote)
Common Stock
Footnotes (2)
- [F1]Consists of shares held by Scheer Investment Holdings III, LLC. Mr Scheer is the Managing Member of Scheer Investment Holdings III, LLC. and as such may be deemed to have shared voting and investment power with respect to the shares held by Scheer Investment Holdings III, LLC. Mr. Scheer disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein.
- [F2]This option was granted on December 18, 2009 and vested over a four year period with 25% of the shares vesting on the first anniversary of the grant date and an additional 6.25% vesting at the end of each three-month period thereafter.